Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC803924340;24341;24342 chr2:178719275;178719274;178719273chr2:179584002;179584001;179584000
N2AB772223389;23390;23391 chr2:178719275;178719274;178719273chr2:179584002;179584001;179584000
N2A679520608;20609;20610 chr2:178719275;178719274;178719273chr2:179584002;179584001;179584000
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: V
  • RefSeq wild type transcript codon: GTC
  • RefSeq wild type template codon: CAG
  • Domain: Ig-65
  • Domain position: 55
  • Structural Position: 135
  • Q(SASA): 0.2466
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
V/I rs759655046 -0.59 0.009 N 0.142 0.063 0.535679682109 gnomAD-2.1.1 1.79E-05 None None None None N None 0 0 None 0 0 None 6.54E-05 None 0 2.34E-05 0
V/I rs759655046 -0.59 0.009 N 0.142 0.063 0.535679682109 gnomAD-3.1.2 3.29E-05 None None None None N None 0 0 0 0 0 None 0 0 4.41E-05 2.07297E-04 4.77555E-04
V/I rs759655046 -0.59 0.009 N 0.142 0.063 0.535679682109 gnomAD-4.0.0 2.41675E-05 None None None None N None 0 1.66667E-05 None 0 0 None 0 0 2.20389E-05 1.20778E-04 1.60046E-05

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
V/A 0.1519 likely_benign 0.1538 benign -1.637 Destabilizing 0.334 N 0.443 neutral D 0.53457691 None None N
V/C 0.6163 likely_pathogenic 0.6338 pathogenic -1.249 Destabilizing 0.992 D 0.527 neutral None None None None N
V/D 0.263 likely_benign 0.2646 benign -1.988 Destabilizing 0.896 D 0.639 neutral N 0.503427284 None None N
V/E 0.2224 likely_benign 0.2352 benign -1.971 Destabilizing 0.92 D 0.609 neutral None None None None N
V/F 0.1242 likely_benign 0.124 benign -1.346 Destabilizing 0.916 D 0.565 neutral N 0.519532886 None None N
V/G 0.1983 likely_benign 0.2018 benign -1.966 Destabilizing 0.896 D 0.627 neutral N 0.472240372 None None N
V/H 0.354 ambiguous 0.3752 ambiguous -1.539 Destabilizing 0.992 D 0.625 neutral None None None None N
V/I 0.0659 likely_benign 0.0661 benign -0.813 Destabilizing 0.009 N 0.142 neutral N 0.462946098 None None N
V/K 0.2351 likely_benign 0.2417 benign -1.244 Destabilizing 0.85 D 0.609 neutral None None None None N
V/L 0.1419 likely_benign 0.1466 benign -0.813 Destabilizing 0.004 N 0.156 neutral N 0.468026631 None None N
V/M 0.1016 likely_benign 0.1093 benign -0.669 Destabilizing 0.85 D 0.487 neutral None None None None N
V/N 0.1764 likely_benign 0.1822 benign -1.146 Destabilizing 0.92 D 0.642 neutral None None None None N
V/P 0.8738 likely_pathogenic 0.8852 pathogenic -1.055 Destabilizing 0.972 D 0.621 neutral None None None None N
V/Q 0.2445 likely_benign 0.2493 benign -1.342 Destabilizing 0.972 D 0.625 neutral None None None None N
V/R 0.2027 likely_benign 0.1975 benign -0.756 Destabilizing 0.92 D 0.656 neutral None None None None N
V/S 0.1561 likely_benign 0.156 benign -1.643 Destabilizing 0.447 N 0.593 neutral None None None None N
V/T 0.1182 likely_benign 0.1208 benign -1.521 Destabilizing 0.021 N 0.291 neutral None None None None N
V/W 0.6379 likely_pathogenic 0.6685 pathogenic -1.581 Destabilizing 0.992 D 0.676 prob.neutral None None None None N
V/Y 0.3561 ambiguous 0.3706 ambiguous -1.265 Destabilizing 0.92 D 0.563 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.